TrialFit

Ranked candidates are only useful if you can see the reasoning.

TrialFit compares the profiles your team provides against the Crohn's and ulcerative colitis eligibility you signed off on, so coordinators know where to start their review. It does not make the decision for them.

Demo Data

18IBD profiles in demo cohort

14IBD eligibility factors applied

88%Average demo match score

Sarah M.

Site 004 — Northside GI

Demo Data

Match score96%

Basis for the score

Ileocolonic Crohn's disease, endoscopically confirmed
CDAI 312 — within moderate-to-severe window
Documented anti-TNF inadequate response

Verify next: Confirm fecal calprotectin and CRP are within the screening window

Emily R.

Site 002 — Lakeview IBD Center

Demo Data

Match score93%

Basis for the score

Ulcerative colitis, left-sided extent
Mayo endoscopic subscore of 2
No biologic exposure — meets naïve cohort

Verify next: Verify corticosteroid taper history before pre-screening call

David K.

Site 007 — Riverbend Gastroenterology

Demo Data

Match score91%

Basis for the score

Crohn's disease with steroid dependence
Disease duration over 6 months at screening
Stable follow-up record at the IBD clinic

Verify next: Review prior bowel resection date against exclusion criteria

Demo Data — names, sites, and match scores are fictional. TrialFlow does not access hospital records and does not identify real patients.

Try it against your own protocol and candidate list.

Request a walkthrough